FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Web Site Warned on Chloroquinelone Sales

[ Price : $8.95]

FDA warns a Web site operating at chloroquineonline.com that it is selling unapproved and misbranded drug products claiming to pre...

Sekisui Diagnostics Osom Ultra Plus Flu Test Cleared

[ Price : $8.95]

FDA clears a Sekisui Diagnostics 510(k) for the Osom Ultra Plus Flu A&B Test.

Combo Compliance Manual Includes Streamlined Approach

[ Price : $8.95]

Hogan Lovells attorneys highlight the provisions in an updated compliance manual for CDER- and CDRH-led combination products.

FDA Acceptance of Real-World Data for Drug Approval

[ Price : $8.95]

Researchers from FDA and drug companies summarize FDAs acceptance of real-world data in drug approvals.

OMB Reviewing FDA Cannabis Document: Report

[ Price : $8.95]

Natural Products Insider says FDA has sent a CBD guidance document to the Office of Management and Budget for review.

Progress Seen in Sex-Inclusive Research

[ Price : $8.95]

Academic researchers find some progress made in sex-inclusive scientific studies but more needs to be accomplished.

Latest FDA Warning Letters

[ Price : $8.95]

FDA releases its latest batch of Warning Letters that includes one medical product company chloroquineonline.com.

FDA Walks Back CDER Testimony on API Volumes

[ Price : $8.95]

FDA walks back misleading testimony by CDER deputy director Douglas Throckmorton who testified at a Senate Finance committee last ...

Homeopathic Drug Regulation Sought

[ Price : $8.95]

Americans for Homeopathy Choice Foundation asks FDA to adopt a regulation specifying requirements for homeopathic drugs and determ...

Senators Introduce FDA Provisional Approval Bill

[ Price : $8.95]

Senators Mike Braun (R-IN), Lisa Murkowski (R-AK), and Martha McSally (R-AZ) introduce the Promising Pathway Act (S. 3872) that wo...